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COSMIN Risk of Bias tool to assess the
quality of studies on reliability or
measurement error of outcome
measurement instruments: a Delphi study
L. B. Mokkink1* , M. Boers1,2, C. P. M. van der Vleuten3, L. M. Bouter1,4, J. Alonso5, D. L. Patrick6,
H. C. W. de Vet1 and C. B. Terwee1
Abstract
Background: Scores on an outcome measurement instrument depend on the type and settings of the instrument
used, how instructions are given to patients, how professionals administer and score the instrument, etc. The
impact of all these sources of variation on scores can be assessed in studies on reliability and measurement error, if
properly designed and analyzed. The aim of this study was to develop standards to assess the quality of studies on
reliability and measurement error of clinician-reported outcome measurement instruments, performance-based
outcome measurement instrument, and laboratory values.
Methods: We conducted a 3-round Delphi study involving 52 panelists.
Results: Consensus was reached on how a comprehensive research question can be deduced from the design of a
reliability study to determine how the results of a study inform us about the quality of the outcome measurement
instrument at issue. Consensus was reached on components of outcome measurement instruments, i.e. the
potential sources of variation. Next, we reached consensus on standards on design requirements (n = 5), standards
on preferred statistical methods for reliability (n = 3) and measurement error (n = 2), and their ratings on a four-
point scale. There was one term for a component and one rating of one standard on which no consensus was
reached, and therefore required a decision by the steering committee.
Conclusion: We developed a tool that enables researchers with and without thorough knowledge on
measurement properties to assess the quality of a study on reliability and measurement error of outcome
measurement instruments.
Keywords: Risk of Bias, Delphi study, Quality assessment, Reliability, Measurement error, Outcome measurement
instruments, COSMIN
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Background
Outcome measurement instruments can be used to
measure changes in relevant constructs within patients
over time in research or clinical practice [1]. Scores of
outcome measurement instruments can be influenced by
many factors (so-called sources of variation), such as the
time or occasion when the measurement was taken, the
instructions that were given to patients, the type of de-
vice or the settings that were used [2, 3]. In a measure-
ment protocol it is specified how the measurements
should be standardized to minimize the influence of
these sources of variation. For example, the Administra-
tion and scoring manual of the Multiple Sclerosis Func-
tional Composite (MSFC) provides detailed instructions
and specification for use [4]. The MSFC consists of four
tasks, one being the Nine Hole Peg test (NHPT) asses-
sing arm and hand function [5]. The required equipment
(e.g. 9-HPT apparatus, stopwatch, 9-HPT Record Form),
including preparation of the equipment (e.g. ‘the appar-
atus should be anchored on a solid table’), instructions
for communication with the patient, a schedule for con-
ducting the test with dominant and non-dominant hand,
and instructions for discontinuing the test and scoring
are described in this measurement protocol. Any devia-
tions from the protocol could lead to different scores.
Reliability studies help to estimate the influence of dif-
ferent sources of variation on scores, in two ways. First,
by studying which sources of variation are most distort-
ing the measurement (i.e. by evaluating the measure-
ment property reliability) [3]. Second, by studying the
amount of error in scores in absolute terms due to
sources of variation as mentioned above (i.e. by evaluat-
ing the measurement property measurement error - in
case of categorical outcomes also called ‘agreement’) [6].
When it is possible to better standardize these sources
of variation, the measurement can be improved – lead-
ing to smaller errors, and less patients required in stud-
ies to find intervention effects [7].
When using a patient-reported outcome measure
(PROM), one of the most relevant source of variation
that we should know is that due to time: patients
complete a PROM at different time points, e.g. before
and after treatment, and we want to be sure that change
in scores reflect real changes and not random or system-
atic variation over time. This is studied in a test-retest
reliability study [8]. Other sources of variation may be
important for other types of instruments, such as
clinician-reported outcome measurement instruments
(ClinROMs) (including e.g. readings based on imaging
modalities and ratings based on observations);
performance-based outcome measurement instruments
(PerFOMs); and biomarker outcomes – also called la-
boratory values [9, 10]. These measurement instruments
are typically more complex as more sources of variation
can potentially influence the scores. More sources of
variation complicate the design, analysis, and reporting
of studies on reliability and measurement error. Depend-
ing on which sources of variation are considered, differ-
ent research questions can be investigated. For example,
intra-rater reliability is assessed when it is studied
whether the measurement results differ when they are
assessed more than once by the same rater; inter-rater
reliability is assessed when it is studied whether the
measurement results differ when they are assessed by
different raters; more complex designs can assess
whether measurement results differ when they are
assessed more than once by different raters at different
time points, or with different equipment, etc. Also, dif-
ferent research questions can be investigated depending
on what part of the measurement instrument (or meas-
urement procedure) is repeated in the reliability study:
i.e. a different research question is studied when the
whole measurement procedure is repeated or when only
a part of the measurement procedure (e.g. only the inter-
pretation of images) is repeated.
High quality studies on measurement error and reli-
ability are needed to get insight in the influence of dif-
ferent sources of variation on measurements and scores.
To evaluate the quality of studies on reliability and
measurement error is a challenging task. We previously
developed the COnsensus-based Standards for the selec-
tion of health Measurement INstruments (COSMIN)
Risk of Bias checklist to assess the quality of studies on
measurement properties of PROMs [11] (updated in
2018 [12], see also [13]). The COSMIN Risk of Bias
checklist includes standards on design requirements and
preferred statistical methods organized in boxes per
measurement property.
In this study, we aimed to extend the COSMIN stan-
dards to assess the quality of studies on reliability and
measurement error of ClinROMs, PerFOMs and labora-
tory values used in health care and research. More spe-
cifically, we aimed to develop a new COSMIN Risk of
Bias tool to transparently and systematically determine
(1) how the results of a study on reliability or measure-
ment error can inform us about the quality of these
types of outcome measurement instruments used in
health care and research, and (2) whether we can trust
the result obtained in the study through an assessment
of its risk of bias. The target user of the Risk of Bias tool
is a clinician or researcher who may or may not be fa-
miliar with all aspects of reliability, and who needs to
understand reliability studies to select outcome measure-
ment instruments. To develop the tool, we conducted a
Delphi study to reach consensus among a group of inter-
national researchers with expertise on reliability and
measurement error studies. A Delphi study is a method
to structure discussion and come to consensus in
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opinion among a group of experts, by means of a series
of surveys [14]. This is especially useful when issues can-
not be empirically studied. In addition, by performing an
online study, experts from around the world were able
to participate.
Methods
Design of the study
This Delphi study consisted of three online survey
rounds. In each round, we asked panelists to rate
their agreement with each of a set of proposals. In
addition, we asked reasons for each rating, to better
understand the opinions of panelist and improve pro-
posals in the next round. Responses were analyzed
anonymously, and all responses were included in a
separate feedback report per round (all documents
are available at https://osf.io/6fnw3). We used Surva-
lyzer (Survalyzer AG, Utrecht, the Netherlands) to
create and disseminate the surveys.
Preparation of the Delphi study
The proposals were based on a literature search and are
in line with current COSMIN terminology and the Risk
of Bias checklist for PROMs [12, 15]. We searched for
systematic reviews on the measurement properties of
ClinROMs, PerFOMs or laboratory values in the COS-
MIN database of systematic reviews on outcome meas-
urement instruments (https://database.cosmin.nl/). This
database contains systematic reviews published in
PubMed and EMBASE on the quality of outcome meas-
urement instruments on any health aspect (for the
search strategy, see the manual of the COSMIN database
available at https://cosmin.nl). The database was up-to-
date until March 2016 when we selected reviews on the
specified types of outcome measurement instruments to
inform and inspire us for this Delphi study. From each
review we extracted any standard that was used to assess
the quality of the design or the appropriateness of statis-
tical methods used of the included studies on reliability
or measurement error in the review. All these standards
were ordered and merged when possible. This overview
was used as input into the Delphi study. The question-
naire for each round was written by one of the authors
(LB) and carefully discussed within a subgroup of the
steering committee (LB, CB, HdV, and MB), in consult-
ation with others (see acknowledgment), and checked
and approved by the whole steering committee (all
authors).
Panelists
We aimed to include persons with expertise in complex
studies on reliability and measurement error of outcome
measurement instruments used in any medical field. We
searched in PubMed and EMBASE for (co-) authors
who published at least 4 studies applying generalizability
theory, as complex reliability and measurement error
studies often need to use generalizability (G-) coeffi-
cients (which are extended Intraclass Correlation Coeffi-
cients (ICCs)) [3, 16]. In collaboration with a clinical
librarian we developed search strings for PUBMED and
EMBASE using terms about Generalizability theory and
source of variance to identify these authors (Additional
file 1). In addition, we invited authors of methodological
publications on reliability and measurement error, and
representatives of scientific organizations focusing on
improving outcome selection such as the International
Society of Quality of Life Research (ISOQOL - specific-
ally via the ISOQOL psychometrics Special Interest
Group), the International Society for Pharmacoeco-
nomics and Outcomes Research (ISPOR), Core Out-
come Measures in Effectiveness Trials (COMET)
initiative, and Outcome Measures in Rheumatology
(OMERACT). We invited people from various health
care fields and countries.
Based on our experience, we anticipated that at the
most 50% of the invited persons would participate in at
least one round. Therefore, we invited approximately
150 people to ensure saturation in arguments.
Content of the rounds
In round 1 (see Fig. 1), we discussed the different com-
ponents of outcome measurement instruments as poten-
tial sources of variation in a reliability study. Also, we
discussed elements that together make up an optimally
comprehensive research question, and how to construe
the research question if it is not clearly formulated in
the publication.
In round 2 we aimed to reach consensus on the issues
left from round 1 based on previous ratings and feed-
back. Based on the comments in round 1 we decided to
make a separate set of components for measurement in-
struments of biological samples (i.e. laboratory values),
and a set for other measurement instruments (i.e. Clin-
ROMs and PerFOMs). We also proposed standards on
design requirements and preferred statistical methods.
In round 3 we aimed to reach final consensus. Issues
without consensus after round 3 were resolved by the
steering committee.
In the Risk of Bias tool, each standard will be scored
on a four-point rating system (i.e. ‘very good’, ‘adequate’,
‘doubtful’, or ‘inadequate’) in line with the COSMIN
Risk of Bias checklist for PROMs [12]. In general, a
standard is rated as ‘very good’ when there is evidence
that the standard is met, or when a preferred method
was optimally used; ‘adequate’ when it is assumable that
the standard is met, or when the preferred method was
used, but it was not optimally applied; ‘doubtful’ when it
is unclear whether or not the standard is met or unclear
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if a preferred method was used; and ‘inadequate’ when
there is evidence provided that the standard is not met
or when the preferred method was not used. Decided a
priori by the steering committee, we only discussed rat-
ings for what constitutes very good, adequate, doubtful
or inadequate preferred statistical methods. The ratings
for what constitutes very good, adequate, doubtful or in-
adequate design requirements were not discussed, as
these were adopted from the COSMIN Risk of Bias
checklist for assessing studies on measurement proper-
ties of PROMs [12]. In every COSMIN box a standard
about ‘other methodological flaws’ is included by default.
In this tool, we also included this standard, without dis-
cussing it.
Analyses
Agreement was rated on a five-point Likert scale (i.e.
strongly disagree to strongly agree, with ‘no opinion’ in
the middle). In addition, a response option ‘no expertise’
was added to each question. Consensus was reached
when at least 67% of the panelists agreed or strongly
agreed with a proposal (the same criterion as used in
previous COSMIN Delphi studies [15, 17]) – panelist
who scored ‘no expertise’ were not taken into account in
the calculation for consensus for the specific item. We
chose this criterion as it indicated that a substantial part
of the panelists agreed to a proposal, whilst retaining
room for panelists with dissenting views. If less than
67% agreement was reached on a proposal, it returned in
the next round, with pro and contra arguments of panel-
ists, and an alternative proposal. LM read all arguments
and made the summary of arguments, all arguments
were provided in the feedback reports and sent to all
panelists and the steering committee members. Promis-
ing proposals for improvement were also posted in the
next round even if consensus had been reached. When
no consensus had been reached after three rounds, a
steering committee – consisting of all authors or this
article - made the final decision. The steering committee
was also responsible for the selection of potential panel-
ists, the content of each round and each feedback report,
the analyses of responses, and the reporting of the study.
The steering committee members did not act as panelist.
Based on all consensus and decisions, the steering
committee developed the ‘COSMIN Risk of Bias tool to
assess the quality of studies on reliability or measure-
ment error of outcome measurement instruments’ and
the ‘COSMIN Risk of Bias tool to assess the quality of a
study on reliability or measurement error of outcome




We invited 161 panelists to participate in round 1 and 2,
of which 52 people (32%) (at least partly) responded to
either round 1 or round 2. Forty-five (87%) invited pan-
elists completed round 1 (and three people partially
completed this round), and 41 (79%) invited panelists
completed round 2 (another five partially). Round 3 was
only sent to the 58 panelists who at least opened the link
to any of the previous rounds; 52 of them participated in
round 1 or round 2, and six panelists opened round 1 or
2, but did not respond to any proposal; 39 (75%) of the
58 invited panelists completed the third round. Thirty-
six panelists (69%) completed all three rounds, 10 (19%)
completed two rounds, and 6 (12%) completed one
round. See Table 1 for descriptive information on the 52
panelists who participated.
Preparatory input to the Delphi study
In the COSMIN database of systematic reviews of out-
come measurement instruments 174 reviews were found
that included ClinROMs, PerFOMs or laboratory values.
Of these, 103 reviews described standards on any meas-
urement property to assess the quality of the study de-
sign or the statistical methods used, of which 30 of these
reviews provided standards specifically for reliability and
measurement error studies (see Additional file 1).
Preparation phase
Extraction of standards from reviews from 
the COSMIN database
Discussion within the steering group
Round 1
Rate agreement on components of outcome 
measurement instruments and on
formulating a comprehensive 
research questions
Round 2
Achieve consensus on issues round 1.
Rate agreement on standards about design 
requirements for reliability studies
Round 3
Achieve consensus on standards about design 
requirements.
Rate agreement on standards about preferred 
statistical methods
Final decisions by steering committee.
Presentation of the COSMIN Risk of Bias 




Fig. 1 Content of the Delphi study
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Through references in these reviews, we found three
methodological papers describing a relevant checklist or
guideline [18–20], one extraction form [21], and one
additional systematic review [22]. All standards from this
literature were used as input in our Delphi study. Im-
portant themes included in these standards were the
standardization of the application of the instrument (e.g.
instructions about specific equipment and settings that
should be used, the environment, the professionals in-
volved (e.g. training), etc.), independency and blinding,
stability of patients, time interval, and statistical
methods. We tested these items on three published stud-
ies in which generalizability theory was applied [23–25],
and subsequently we realized that the research questions
in these papers were not specific enough to assess
whether the chosen design and statistical models were
appropriate. Based on these experiences we felt the need
to disentangle steps in the process of assessing the qual-
ity of a study on reliability or measurement error, into
(1) understanding how exactly results of a study in-
formed us about the quality of an instrument, and (2)
assessing the quality of the study. As a basic foundation
to elaborate these two steps, we decided to first identify
all general components (i.e. potential sources of vari-
ation) of a measurement instrument.
Components of outcome measurement instruments
In round 1 we started with a list of components of out-
come measurement instruments that can be considered
potential sources of variation that can influence the
Table 1 Descriptive information of the panelists (n = 52)














Reason for invitationa PubMed or EMBASE search 4
Author of review on non-PROMs 3
Author of methodological paper on reliability 16
Representative of relevant organization 18
Own network only 9
Nominated by invited panelist 4









Ever used one of the COSMIN tools? Yes 29
No 23
a multiple answers allowed, b 56% of the panelists indicated to have more than one profession (up to 5)
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score on the measurement instrument. Based on panel-
ists’ suggestions and comments, in round 2 the steering
committee decided to propose two sets of components,
one for outcome measurement instruments that involve
biological sampling (i.e. blood or urine tests, tissue bi-
opsy), and one for those that do not (i.e. ClinROMs and
PerFOMs). This was proposed because the words ‘data’
and ‘score’ that we proposed to use for specific compo-
nents were not considered appropriate for laboratory
values. We reached consensus to use the words ‘bio-
logical sample’ and ‘value’, respectively, for outcome
measurement instruments that involve biological sam-
pling. Except for one, we reached consensus on all terms
for the components and their elaboration (see Tables 2
and 3 and Additional file 1 for an elaboration). For the
remaining issue, the steering committee decided to use
the term ‘determination of the value of the biological
sample’ over its alternative ‘actual measurement of the
value of the biological sample’.
Elements of a comprehensive research question
In order to understand how exactly the result of a reli-
ability study informs us on the quality of the measure-
ment instrument under study, in round 1 we agreed on
7 elements that can be disentangled from the described
design of the study and together form a comprehensive
research question (Table 4). In round 2 we proposed an
alternative wording for element 4 (see Additional file 1).
As a result, agreement on this element increased from
70 to 86%.
Standards on design requirements of studies on reliability
and measurement error
To assess reliability or measurement error of an out-
come measurement instrument repeated measurements
in stable patients are required. The design of a study
assessing any of the two measurement properties is the
same, i.e. the same data can be used for estimating reli-
ability and measurement error. Only different statistical
parameters are applied to the same data to express both
measurement properties.
In round 2 we reached consensus on five standards on
design requirements, referring to stable patients, appro-
priate time interval, similar measurement conditions,
and independent measurements and scoring (Table 5).
Alternative wordings for the standards 4 and 5 increased
consensus for these standards from 73 and 78%, respect-
ively, to 92% in round 3.
Standards on preferred statistical methods of studies on
reliability
We reached consensus on three standards (Table 6) on
preferred statistical methods to assess reliability of out-
come measures that have continuous, ordinal and di-
chotomous/nominal scores, respectively, and how these
standards should be rated. Preferred statistical methods
are ICCs and (weighted) Kappa. Based on suggestions by
Table 2 Consensus of components of outcome measurement instruments that do not involve biological sampling
Component Consensusa on
the term (%)
Elaboration Consensus on the
elaboration (%)
Equipment 43/48 (90%) (R2b) All equipment used in preparation, administration, and assigning scores 43/48 (90%) (R2)
Preparatory
actions
38/46 (83%) (R2) 1. ‘First time only’ general preparatory actions, such as required expertise or training
for professionals to prepare, administer, store or assign the scores
2. Specific preparatory actions for each measurement, such as
• preparations of equipment by professionalsc
• preparations of the patientd by the professional




30/44 (68%) (R2) What the patient and/or professional(s) actually do to obtain the unprocessed data 33/44 (75%) (R2)
Data processing
and storage









36/44 (82%) (R2) Methods used to transform processed data into a final scoree on the outcome
measurement instrument.
34/44 (77%) (R2)
a Consensus was set at 67% of the panelists (strongly) agreed to a proposal, the denominator can be decreased because panelists considered themselves to have
‘no expertise’ on a specific proposal or dropped-out; b R2: consensus reached in Round 2; c Professionals are those who are involved in the preparation or the
performance of the measurement, in the data processing, or in the assignment of the score; this may be done by one and the same person, or by different
persons; d In the COSMIN methodology we use the word ‘patient.’ However, sometimes the target population is not patients, but e.g. healthy individuals,
caregivers, clinicians, or body structures (e.g. joints, or lesions). In these cases, the word patient should be read as e.g. healthy volunteer, or clinician; e The score
can be further used or interpreted by converting a score to another scale, metric or classification. For example, a continuous score is classified into an ordinal
score (e.g. mild/moderate/severe), a score is dichotomized into below or above a normal value, patients are classified as responder to the intervention (e.g. when
their change is larger than the Minimal Important Change (MIC) value)
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Equipment See above All equipment used in the preparation, the administration, and
the determination of the values of the outcome measurement
instrument
See above
Preparatory actions preceding sample
collection by professionals, patients, and others
(if applicable)
See above 1. General preparatory actions, such as required expertise or
training for professionals to prepare, administer, store and
determine the value
2. Specific preparatory actions for each measurement, such as
• preparations of equipment, environment, and storage by
professionalsb
• preparation of the patientc by the professional
• Preparatory actions undertaken by the patients
See above
Collection of biological sample 32/38 (84%)
(R2d)









All actions undertaken to be able to preserve, transport, and store
the biological sample for determination; and, if applicable, further
actions undertaken on the stored sample to be able to conduct
the determination of the biological sample
35/36 (97%) (R3)




Methods used for counting or quantifying the amount of the
substance or entity of interesth
27/36 (75%) (R3)
a Consensus was set at 67% of the panelists (strongly) agreed to a proposal, the denominator can be decreased because panelists considered themselves to have
‘no expertise’ on a specific proposal or dropped-out; b Professionals are those who are involved in the preparation or the performance of the measurement, in the
data processing, or in the assignment of the score; this may be done by one and the same person, or by different persons; c In the COSMIN methodology we use
the word ‘patient.’ However, sometimes the target population is not patients, but e.g. healthy individuals, caregivers, clinicians, or body structures (e.g. joints, or
lesions). In these cases, the word patient should be read as e.g. healthy volunteer, or clinician; d R2: consensus reached R2: consensus reached in Round 2; e After
round 2 we changed the formulation, but we did not rated agreement among panelists; f In round 2 we proposed two components ‘initial processing and
storage’ and ‘second processing’, which we proposed to combine in Round 3; g R3: consensus reached in Round 3; h Decision by the steering committee; i
Consensus reached in R3 on the term ‘value’
Table 4 Elements of a comprehensive research question of a study on reliability or measurement error
Element of the research question Consensusa (%)
1 the name of the outcome measurement instrument 42/45 (93%) (R1b)
2 the version of the outcome measurement instrument or way of operationalization of the measurement protocolc 42/45 (93%) (R1) (version)
33/45 (73%) (R1)
(operationalization)
3 the construct measured by the measurement instrument 40/45 (89%) (R1)
4 a specification whether one is interested in a reliability parameter (i.e. a relative parameter such as an ICC,
Generalizability coefficient φ, or Kappa κ) or a parameter of measurement error (i.e. an absolute parameter
expressed in the unit of measurement e.g. SEM, LoA or SDC; or expressed as agreement or misclassification, e.g. the
percentage specific agreement).
36/42 (86%) (R2d)
5 a specification of the components of the measurement instrument that will be repeated (especially when only
part of the measurement instrument is repeated, e.g. only assignment of the score based on the same images)
38/45 (84%) (R1)
6 a specification of the source(s) of variation that will be variede 41/45 (91%) (R1)
7 a specification of the patientf populationg studied 42/45 (93%) (R1)
a Consensus was set at 67% of the panelists (strongly) agreed to a proposal, the denominator can be decreased because panelists considered themselves to have
‘no expertise’ on a specific proposal or dropped-out; b R1: consensus reached in Round 1; c In Generalizability theory these are the facets of stratification (FoS),
when patients are nested in a facet [16]; d R2: consensus reached in Round 2; e In Generalizability theory these are the random or fixed facets of generalizability
(FoG), e.g. time or occasion, the (level of expertise of) professionals, the machines, or other components of the measurement [16]; f In the COSMIN methodology
we use the word patient. However, sometimes the target population doesn’t consist of patients, but e.g. healthy individuals, caregivers, clinicians, or the
body structures (e.g. joints, or lesions). In these cases, the word patient should be read as e.g. healthy volunteer, or clinician; g In Generalizability theory these are
the Object of Measurement (OoM) or the facet of differentiation [16]
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the panelists, we asked in round 3 whether we should
add that when the data was non-normally distributed
standard 7 for continuous scores should be rated as in-
adequate – for which we did not reach consensus (i.e.
54%) and this proposal was therefore not included in the
standard. The most important issue was the relatively
low degree of consensus on the kappa statistic as a pre-
ferred statistical methods to assess reliability of ordinal
scores (standard 8 for reliability): 67% agreed in round 2
that weighted kappa was the preferred statistical method
to assess reliability for ordinal scores (standards 8 for re-
liability), and 56% agreed in round 2 that kappa was the
Table 5 Standards for design requirements of studies on reliability or measurement error
Design requirements very good adequate doubtful inadequate NA
1 Were patients stable in the time between the repeated measurements on
the construct to be measured?










2 Was the time interval between the repeated measurements appropriate?





3 Were the measurement condition similar for the repeated measurements
– except for the condition being evaluated as a source of variation?












4 Did the professional(s) administer the measurement without knowledge
of scores or values of other repeated measurement(s) in the same
patients?










5 Did the professional(s) assign the scores or determined the values without
knowledge of the scores or values of other repeated measurement(s) in
the same patients?









6 Were there any other important flaws in the design or statistical methods





a R2: consensus reached in round 2; b R3: consensus reached in round 3; c Standard 6 and the responses of the four-point rating system were not discussed in the
Delphi study
Table 6 Consensus reached on standards for preferred statistical methods for reliability
Statistical methods very good adequate doubtful inadequate





model or formula was
described, and matches
the study designc and
the data
30/35 (86%)(R2)
ICC calculated but model or formula
was not described or does not
optimally match the study designc
OR
Pearson or Spearman correlation
coefficient calculated WITH evidence
provided that no systematic
difference between measurements
has occurred
Pearson or Spearman correlation
coefficient calculated WITHOUT















the study design and the
data
R3: 27/36 (75%)(R3d)
Kappa calculated, but weighting
scheme not described or does not
optimally match the study design
19/36 (53%)(R3)
9 For dichotomous/nominal
scores: was Kappa calculated








a Generalizability and Decision coefficients are ICCs; b R2: consensus reached in round 2; c Based on panelists’ suggestions the steering committee decided after
round 3 to use the word ‘study design’ instead of ‘reviewer constructed research question’; d R3: consensus reached in round 3
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preferred statistical methods to assess reliability for di-
chotomous/nominal scores (standard 9). Issues raised in-
cluded the difficulty in interpreting a kappa value, and
the dependence on the prevalence of a specific outcome
(i.e. the heterogeneity of the sample). Panelists recom-
mended reporting the marginals, as well as the percent-
age specific agreement. However, specific agreement is
considered to be a parameter of measurement error
(agreement), and therefore cannot be proposed as a pre-
ferred statistical method to assess reliability. In round 3
we again proposed the (weighted) kappa as the preferred
statistical method to assess reliability of ordinal scores,
while acknowledging that reliability is less informative
than measurement error (standard 8 for reliability), and
for dichotomous/nominal scores kappa was proposed
calculated for each category against the other categories
combined (standard 9 for reliability). The percentage
consensus for standards 8 and 9 for reliability increased
up to 73 and 71%, respectively.
We did not reach consensus on what is considered an
adequate method to assess reliability of ordinal scores
(standard 8 for reliability). In round 2 60% of the panel-
ists agreed or strongly agreed to the proposal to rate the
standard as ‘adequate’ when in a study ‘the weighted
kappa was calculated, but the weighting scheme was not
described’. In round 3 we proposed to rate the standard
as ‘adequate’ when ‘the kappa is calculated, but weight-
ing scheme is not described or does not optimally match
the reviewer constructed research question’. This pro-
posal was in line with the proposal for the preferred stat-
istical method to assess reliability of continuous scores.
Only 54% agreed or strongly agreed to this proposal. In
round 2 62% consensus was reached on the proposal to
rate a study using the unweighted kappa statistic for or-
dinal scores as ‘doubtful’, while in round 3 only 49%
(strongly) agreed to rate a study as ‘adequate’ when the
unweighted kappa statistic was used. Panelists argued
that the weighted kappa is mathematically the same as
the ICC. After round 3, we further discussed this issue
within the steering committee, and decided to keep it as
suggested in round 3 (Table 6) to be in line with the
standard for continuous scores.
Standards on preferred statistical methods of studies on
measurement error
We reached consensus on two standards on preferred
statistical methods to assess measurement error
(Table 7). For continuous scores (standard 7 for meas-
urement error) we reached consensus that the Standard
Error of Measurement (SEM), Smallest Detectable
Change (SDC), Limits of Agreement (LoA) or Coeffi-
cient of Variation (CV) were the preferred statistical
methods, and for ordinal/dichotomous/nominal scores
(standard 8 for measurement error) the percentage
specific (e.g. positive and negative) agreement was pre-
ferred (see Table 7). In round 3 we agreed on an alterna-
tive wording for the responses of the four-point rating
system of the standard for continuous scores, to be in
line with the proposed wording for the standard on reli-
ability for continuous scores.
Sometimes Cronbach’s alpha instead of the ICC is
used to calculate the measurement error with the for-
mula SEM ¼ σy
ffiffiffiffið1p − ICCÞ , where σy represents the
standard deviation (SD) of the sample [26]. The panelists
agreed this method is inadequate, because it is based on
one full-scale measurement where items are considered
as the repeated measurements, instead of at least two
full-scale measurements using the total score in the cal-
culation of the SEM. Moreover, Cronbach’s alpha is
sometimes used inadequately, because it is calculated for
a scale that is not unidimensional, or based on a forma-
tive model. In such cases the Cronbach’s alpha cannot
be interpreted. Some panelists argued that this method
of SEM calculation was better than nothing. With the
explanation that a rating of ‘inadequate’ means that the
SEM resulting from such a study can still be used, but
the results are less trustworthy, 72% agreed to rate ‘a
SEM calculated based on Cronbach’s alpha, or using SD
from another population’ as ‘inadequate’.
In round 2 we reached 53% consensus to consider the
Coefficient of Variation (CV) as the preferred statistical
method to assess measurement error for scales with pro-
portion or percentage scores. Several panelists pointed
out that the CV is also frequently used for continuous
scores, specifically for laboratory values. Therefore, we
proposed that the CV is also an appropriate statistical
method for continuous scores on measurement error
(add it to standard 7 for measurement error), and
reached 73% consensus.
Term for ‘research question’
One final issue remained without consensus. In gen-
eral, the statistical methods should match the re-
search question and study design. We proposed to
state that the statistical methods should match the
‘retrospectively formulated research question’ (round
2) or the ‘reviewer constructed research question’
(round 3). However, some panelists considered the
term ‘retrospectively’ unclear and inappropriate as it
could be interpreted that the research question was
defined afterwards (while we meant that it was com-
prehensively formulated afterwards). The term ‘re-
viewer constructed research question’ was also
considered unclear, as it was not very clear to whom
‘reviewer’ referred to (i.e. the one who is using the
Risk of Bias tool and reviews a study). The steering
committee finally decided to use the term ‘study
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design’ instead, and to state in the standards that the
statistical methods should match the ‘study design’.
Discussion
We developed a consensus-based ‘COSMIN Risk of Bias
tool to assess the quality of studies on reliability and
measurement error of outcome measurement instru-
ments’, specifically ClinROMs, PerFOMs, and laboratory
values, that are used in health care and research. It com-
prises two parts: (1) seven elements that make up a com-
prehensive research question of the study, which
informs us on the quality of the outcome measurement
instrument under study, and (2) standards on design re-
quirements (n = 5) and preferred statistical methods of
studies on reliability (n = 3) and measurement error (n =
2), which can be used to assess the quality of the study.
The tool allows transparent and systematic determin-
ation of the quality of a study on reliability or measure-
ment error. It guides assessment of the risk of bias, i.e.
the level of trust we can place in the results, and
whether the estimated parameter in the study is not sys-
tematically over- or underestimated. More information
on the tool can be found in the user manual available on
the website https://cosmin.nl.
The COSMIN Risk of Bias tool to assess the quality of
a study on reliability or measurement error can be used,
for example, in a systematic review of outcome measure-
ment instruments. The COSMIN methodology for con-
ducting systematic reviews of outcome measurement
instruments [27] was developed specifically for PROMs.
In general, this methodology can also be used for con-
ducting systematic reviews of other types of outcome
measurement instruments, incorporating the new Risk
of Bias tool for studies on reliability or measurement
error. Guidelines for how to incorporate it are described
in the user manual.
The new tool was developed specifically for Clin-
ROMs, PerFOMs, and laboratory values. This tool can
also be used to assess the quality of studies on reliability
or measurement error of PROMs or observer-reported
outcome measures (ObsROMs), for example if it is used
in a systematic review in which different types outcome
measurement instruments are included. However, for
the latter types of instruments the tool may seem un-
necessarily complex. The first step in the tool (i.e. un-
derstanding how the results inform us on the quality of
the measurement instrument under study) is often obvi-
ous, as the aim of reliability studies of PROMs and
ObsROMs is most often to assess test-retest reliability
or measurement error of the whole measurement instru-
ment. The second step in the tool (assessing the quality
of the study using the standards) will lead to the same
rating compared to using the standards of the Risk of
Bias checklist for PROMs. The first three standards on
design requirements in both tools are the same. The
standards 4 and 5 (i.e. about administrating the meas-
urement and assigning scores without knowledge on
other repeated measurements, respectively) that are in-
cluded in the new Risk of Bias tool are usually not ap-
plicable to PROMs and ObsROMs, except when the aim
is to assess whether the involvement of different proxies
(e.g. the mother versus the father) influenced the score.
However, this issue can also be taken into account in
standard 3 of the Risk of Bias checklist for PROMs on
the similarity of test conditions, or in standard 6 (add-
itional flaws) in case the COSMIN checklist for PROMs
Table 7 Consensus reached on standards for preferred statistical methods for measurement error (agreement)
Statistical methods very good adequate doubtful inadequate
7 For continuous scores: was the
Standard Error of Measurement
(SEM), Smallest Detectable
Change (SDC), Limits of
Agreement (LoA) or Coefficient
of Variation (CV) calculated?
Relevance: 29/38 (76%)(R2a);
wording: 22/32 (69%)(R3b); add
CV: 22/30 (73%)(R3)
SEM, SDC, LoA or CV
calculated; the model or
formula for the SEM/SDC is
described; it matches the
study designc and the data
32/36 (89%)(R2)
SEM, SDC, LoA or CV calculated,
but the model or formula is not
described or does not optimally
match the study design and





LoA or CV calculated, without
knowledge about systematic
















8 For dichotomous/ nominal/
ordinal scores: Was the







a R2: consensus reached in round 2; b R3: consensus reached in round 3; c Based on panelists’ suggestions the steering committee decided after round 3 to use
the word ‘study design’ instead of ‘reviewer constructed research question’
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is used. The response options for standards on preferred
statistical methods in the new tool are somewhat differ-
ently formulated, but will lead to the same rating.
Comparison with existing literature
It was our aim to develop a risk of bias tool, not a study
design checklist, nor a reporting guideline. Therefore,
we did not include standards referring to the relevance
or generalizability of the study results. For example, we
did not include standards about choices regarding the
inclusion of patients or professionals (e.g. well-trained),
or how the measurement procedure was carried out. In
other existing checklists such standards were included.
For example, the first item in the Quality Appraisal of
Reliability Studies (QAREL) checklist [20] is ‘Was the
test evaluated in a sample of subjects who were repre-
sentative of those to whom the authors intended the re-
sults to be applied?’. This refers to the generalizability of
the results, but it does not refer to the quality of the
study.
Other checklists have a different scope. The Guidelines
for Reporting Reliability and Agreement Studies (GRAS
S) are reporting guidelines [19], and therefore include
items referring to the relevance and the generalizability
of the study. For example items about the description of
the patient population and rater population are included.
The QAREL checklist [20] and the Quality Assessment
of Diagnostic Accuracy Studies (QUADAS-2) [18] are
checklists to assess the quality of studies on accuracy of
diagnostic tests, while the COSMIN Risk of Bias tool fo-
cusses on outcome measurement instruments.
Strength & Limitations
The strength of our study was that we focused on the ar-
guments instead of solely on the percentage consensus
reached on proposals. We valued the comments and ar-
guments provided by the panelists highly. After each rat-
ing on each proposal we asked panelists to provide their
arguments. Also, we gave the opportunity to comment
on the proposals or the study in general in each round.
The arguments enabled us to make better proposals in
the next round. For example, we improved the formula-
tions of standard 4 on design requirements, where we
proposed to ask whether ‘professionals independently
administer the repeated measurement’. Based on sugges-
tions by panelists we changed it into whether ‘profes-
sionals administered the measurements without
knowledge of the scores of other repeated measure-
ments’. Even when we reached consensus (i.e. 67% or
more of the panelists agreed or strongly agreed to a pro-
posal) we occasionally made an alternative proposal in
the next round, if valid arguments were provided which
led to a better proposal. In addition, we think that panel-
ists can better participate in the discussion when
summaries of pro and contra arguments are provided.
All comments were thoroughly read by one of the au-
thors (LM), and part of them were read by one or more
of the other co-authors. In addition to a full feedback re-
port, a summary of the arguments per proposal was also
given in the next round, when necessary.
There were three issues on which no consensus was
achieved after three rounds, which were on the terms
‘determination of the value of the sample’, and ‘reviewer
constructed research question’, and on the most ad-
equate rating for the standard on reliability for ordinal
scores. We discussed these issues in the steering com-
mittee by means of a similar approach as we did in the
Delphi study. LM summarized all arguments per issue,
and asked the other steering committee members to rate
their agreement or preference on the proposals for these
three issues and provide arguments. We think that be-
cause we received a number of arguments to facilitate
our choice, we were in line with the opinions of the
panelists.
The response rate of potential panelists actually par-
ticipating to our study was lower than of previous COS-
MIN studies: 45/161 (28%) participated in round 1 in
this study, while in the COSMIN Delphi study to de-
velop the taxonomy and original Risk of Bias checklist
42/91 (46%) participated in round 1 [15] and in the
COSMIN Delphi study for content validity 158/340
(46%) participated in the first round [17]. The lower re-
sponse rate could to be due to the fact that in round 1
we started with a survey asking questions about the
components of outcome measurement instruments, and
therefore, people with a methodological background
might be put off to participate to this Delphi study. As
we don’t know how much expertise panelists had with
the different types of outcome measurement instru-
ments, this could have influenced in the results of the
consensus on the components of measurement instru-
ments. Also, we asked people an hour of their time per
round. This might have prevented people from partici-
pating to this study. However, we received around 40 re-
sponses in each round, reached consensus within the
panel on most standards and harvested many useful re-
marks and comments. Next, six of the 52 participating
panelists responded to one round only. By personal
email contact, three of them indicated that they couldn’t
participate to a round due to time restrictions, and one
was with maternity leave after round 1.
Future research
In this study, we focused on ‘preferred statistical
methods’, referring to methods that are appropriate for
evaluating reliability or measurement error of outcome
measurement instruments and are commonly used in
the literature. Other methods may be appropriate as well
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(for example bi-factor models [28] or Multi-Trait Multi-
Method (MTMM) analyses [29], or newly developed
methods). It was not our intention to comprehensively
describe all possible statistical methods. When these
methods become common practice, the standards for
statistics possibly need adaptation to accommodate
newer methods.
In some of the standards on preferred statistical
methods it is stated that the ICC model or formula
should match the study design and the data (e.g. stan-
dards 7 for reliability and for measurement error). Statis-
tical knowledge is required to answer this question,
especially in complex situations. Text books e.g. [2, 3],
or methodological papers e.g. [16, 30, 31] on ICC or
Generalizability theory are available. However, these are
often written in the context of psychology and educa-
tion, and require extensive statistical knowledge. More
accessible papers would increase the understanding and
facilitate the choice for the appropriate ICC model.
Conclusion
The COSMIN Risk of Bias tool to assess the quality of a
study on reliability or measurement error aims to enable
clinicians or researchers who may or may not be familiar
with all aspects of reliability to assess the quality of these
studies in a systematic and transparent way, for example
in the context of a systematic reviews on outcome meas-
urement instruments. Furthermore, the consensus we
reached on the construction of a comprehensive re-
search question can facilitate future researchers to better
report their research question in studies on reliability or
measurement error.
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